Abstract
Sandhoff disease occurs in the Christian Maronite community in Cyprus, a community that established over a thousand years ago. Nowadays, this community comprises less than 1% of the whole population, and has been culturally and socially isolated. Cultured fibroblasts from a patient from this inbred group showed a β-hexosaminidase β subunit mRNA of apparently the normal size but of reduced quantity. A mutational analysis of cDNA obtained by polymerase chain reaction amplification of mRNA showed a deletion of A at nt 76 (counted from A of the initiation codon, ATG). The deletion results in a frame shift and a premature termination within 20 amino acids from the N-terminus of the normal mature enzyme protein. The patient was homozygous for the deletion. The 5′-end of the gene showed many discrepancies from the previously published sequence. We consider that these differences are probably polymorphisms of little functional significance, because the patient's fibroblasts generate decreased but stable mRNA and because some of these base changes were also found in the genes from control fibroblasts. An extensive evaluation of the prevalence of this mutant allele in this community is being initiated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arpaia E, Dumbrille-Ross A, Maler T, Neote K, Tropak M, Troxel C, Stirling JS, Pitts JS, Bapat B, Lamhonwah AM, Mahuran DJ, Schuster SM, Clarke JTR, Lowden JA, Gravel RA (1988) Identification of an altered splice site in Ashkenazi Tay-Sachs disease. Nature 333:85–86
Cantor RM, Kaback MM (1985) Sandhoff disease (SHD) heterozygote frequencies (HF) in North American (NA), Jewish (J) and non-Jewish (NJ) populations: implication for carrier screening (abstract). Am J Human Genet 37:A48
Der Khaloustian VM, Khoury MJ, Hallal R, Idriss ZH, Deeb ME, Wakid NW, Haddad FS (1981) Sandhoff disease: a prevalent form of infantile GM2 gangliosidosis in Lebanon. Am J Hum Genet 33:85–89
Dos Santos MR, Tanaka A, Sá Miranda MC, Ribeiro MG, Maia M, Suzuki K (1991) GM2-gangliosidosis B1 variant: analysis of β-hexosaminidase a gene mutations in eleven patients from a defined region in Portugal. Am J Hum Genet 49:886–890
Gravel RA, Clarke JTR, Kaback MM, Mahuran D, Sandhoff K, Suzuki K (1994) The GM2 gangliosidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. 7th edn. McGraw-Hill, New York (in press)
Korneluk RG, Mahuran DJ, Neote K, Klavins MH, O'Dowed BF, Tropack M, Willard HF, Anderson M-J, Lowden JA, Gravel RA (1986) Isolation of cDNA clones coding for the α-subunit of human β-hexosaminidase. Extensive homology between the αand β-subunits and studies on Tay-Sachs disease. J Biol Chem 261:8407–8413
Myerowitz R (1988) Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group. Proc Natl Acad Sci USA 85:3955–3958
Myerowitz R, Costigan C (1988) The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the α-chain of β-hexosaminidase. J Biol Chem 263:18587–18589
Myerowitz R, Hogikyan ND (1986) Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease. Science 232:1646–1648
Navon R (1991) Molecular and clinical heterogeneity of adult GM2 gangliosidosis. Dev Neurosci 13:295–298
Navon R, Proia RL (1989) The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science 243:1471–1474
Neote K, Bapat B, Dumbrille-Ross A, Troxel C, Schuster SM, Mahuran DJ, Gravel RA (1988) Characterization of the human HEXB gene encoding lysosomal β-hexosaminidase. Genomics 3:279–286
Neote K, IcInnes B, Mahuaran DJ, Gravel R (1990) Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J Clin Invest 86:1524–1531
Ohno K, Suzuki K (1988) A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexosaminidase α chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease. Biochem Biophys Res Commun 153:463–469
Proia RL (1988) Gene encoding the human β-hexosaminidase β chain: extensive homology of intron placement in the α- and β- genes. Proc Natl Acad Sci USA 85:1883–1887
Sambrook J, Fritch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989) The GM2-gangliosidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. 6th edn. McGraw-Hill, New York, pp 1807–1839
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Suzuki K, Vanier MT (1991) Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as the prototype. Dev Neurosci 13:288–294
Vanier MT, Ferlinz K, Rousson R, Duthel S, Louisot P, Sandhoff K, Suzuki K (1993) Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa. Hum Genet 92:325–330
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hara, Y., Ioannou, P., Drousiotou, A. et al. Mutation analysis of a Sandhoff disease patient in the Maronite community in Cyprus. Hum Genet 94, 136–140 (1994). https://doi.org/10.1007/BF00202858
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00202858